Yu, Ruili
Cai, Lili
Yang, Bo
Funding for this research was provided by:
the Beijing Municipal Commission of Education and Natural Science Foundation of Beijing Municipality ((Grant No. KZ202110025030), (Grant No. KZ202110025030), (Grant No. KZ202110025030))
Science and technology research and development project of China National Railway Group Co ((Grant No. J2019Z603), (Grant No. J2019Z603), (Grant No. J2019Z603))
Open Research Funding of Laboratory of Beijing Key Laboratory of tumor therapeutic vaccine of Capital Medical University Affiliated Beijing Shijitan Hospital ((Grant No. 2020-KF03), (Grant No. 2020-KF03), (Grant No. 2020-KF03))
Article History
Received: 14 June 2023
Accepted: 25 August 2023
First Online: 30 August 2023
Declarations
:
: The NCHS Research Ethics Review Board reviewed and approved NHANES, and all survey participants provided signed informed consent. Therefore, no further ethical approval and informed consent were required to perform the secondary analyses undertaken in this manuscript. The NCHS Research Ethics Review Board Approval can be found on the NHANES website (ExternalRef removed). Additionally, all NHANES data released by the NCHS are de-identified and remain anonymous during data analysis.
: Not applicable.
: The authors declare no competing interests.